Evaluating the performance of the Montreal Cognitive Assessment in early stage Parkinson's disease.

Parkinsonism Relat Disord

The Department of Veterans Affairs (VA), Center for Innovation in Complex Chronic Healthcare & Research Service, Edward Hines Jr. VA Hospital, PO 5000 S. 5th Avenue, Bldg. 1, (M/C 151H), Hines, IL 60141, USA; Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Published: April 2017

Introduction: Mild cognitive impairment is common in Parkinson's disease, even in the early stages, and can be a risk for developing dementia. To properly track development and progression of cognitive impairment, reliable measurement tools are necessary. The Montreal Cognitive Assessment is currently used as a global cognitive screening tool and has been recommended as an abbreviated diagnostic tool to measure mild cognitive impairment in the context of global cognitive function. However psychometric properties of the Montreal Cognitive Assessment in PD have not been assessed in this context.

Methods: Data were obtained from the Parkinson's Progression Markers Initiative (n = 395). We examine psychometric properties of the Montreal Cognitive Assessment among newly diagnosed Parkinson's disease patients using Rasch analysis.

Results: Only one item misfit the measurement model and principle component analysis indicated the Montreal Cognitive Assessment was unidimensional. Distribution of items calibrations formed a logical hierarchy from least to most challenging. Test items were markedly off-target (i.e., too easy) for this sample; this was also reflected in low person separation reliability. While 37% of participants performed all items correctly indicating a large ceiling effect, 22% of participants obtained a raw score in the range of 21-25 indicating mild cognitive impairment. No meaningful differential item functioning was detected.

Conclusion: Results suggest that in the context of early stage Parkinson's disease, the Montreal Cognitive Assessment is a unidimensional measure of global cognitive function. Implications for the use of the Montreal Cognitive Assessment in early stage Parkinson's disease and potential improvements to the assessment are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.01.012DOI Listing

Publication Analysis

Top Keywords

montreal cognitive
28
cognitive assessment
28
parkinson's disease
20
cognitive impairment
16
cognitive
14
early stage
12
stage parkinson's
12
mild cognitive
12
global cognitive
12
assessment
8

Similar Publications

Neurocognitive Functioning in Tourette Syndrome: From Research Findings to Clinical Implementation.

Psychiatr Clin North Am

March 2025

UCL Great Ormond Street Institute of Child Health (ICH), London, UK; Neuropsychology Service, Psychological and Mental Health Services, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Individuals living with Tourette syndrome (TS) may benefit from cognitive assessment, as it may elucidate specific difficulties for which someone could receive accommodation and highlight relative strengths to build upon. Eventually, cognitive assessment could help predicting symptom trajectory or treatment outcome. However, the literature on cognition in TS is often equivocal, which may be at least partly attributed to small samples, inconsistent consideration of co-occurring conditions, psychotropic medication, and developmental influence.

View Article and Find Full Text PDF

Abnormal glymphatic system in patients with autoimmune encephalitis: relationship with cognitive performance.

Brain Res Bull

January 2025

Department of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, 710038, Shaanxi Province, China. Electronic address:

Objectives: We aimed to explore the impact of glymphatic function in patients diagnosed with autoimmune encephalitis (AE).

Methods: In this prospective longitudinal study, patients were recruited from Xijing Hospital between June 2020 and January 2024. Glymphatic function was evaluated using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS).

View Article and Find Full Text PDF

Plasma phosphorylated tau biomarkers open unprecedented opportunities for identifying carriers of Alzheimer's disease pathophysiology in early disease stages using minimally invasive techniques. Plasma p-tau biomarkers are believed to reflect tau phosphorylation and secretion. However, it remains unclear to what extent the magnitude of plasma p-tau abnormalities reflects neuronal network disturbance in the form of cognitive impairment.

View Article and Find Full Text PDF

It is well-known that the use of vocabulary in phenotype treatments is often inconsistent. An earlier survey of biologists who create or use phenotypic characters revealed that this lack of standardization leads to ambiguities, frustrating both the consumers and producers of phenotypic data. Such ambiguities are challenging for biologists, and more so for Artificial Intelligence, to resolve.

View Article and Find Full Text PDF

Objective: The primary goal was to investigate whether the presence of preoperative lacunar infarcts (LACI) was associated with postoperative delirium (POD) in elderly patients undergoing elective major abdominal surgery.

Design: A prospective cohort study.

Setting And Participants: Patients aged ≥ 65 years from a tertiary level A hospital in China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!